ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,315 | +88712.5% | 10,500 | 0.0% | 0.01% | -9.1% |
Q2 2023 | $24 | -25.0% | 10,500 | 0.0% | 0.01% | -26.7% |
Q1 2023 | $32 | +33.3% | 10,500 | 0.0% | 0.02% | +25.0% |
Q4 2022 | $24 | -99.9% | 10,500 | 0.0% | 0.01% | +20.0% |
Q3 2022 | $20,000 | -28.6% | 10,500 | 0.0% | 0.01% | -28.6% |
Q2 2022 | $28,000 | -9.7% | 10,500 | 0.0% | 0.01% | +16.7% |
Q1 2022 | $31,000 | – | 10,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
Shay Capital LLC | 60,000 | $257,000 | 0.03% |
Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |